85 related articles for article (PubMed ID: 9824161)
1. A domain necessary for the transforming activity of SnoN is required for specific DNA binding, transcriptional repression and interaction with TAF(II)110.
Cohen SB; Nicol R; Stavnezer E
Oncogene; 1998 Nov; 17(19):2505-13. PubMed ID: 9824161
[TBL] [Abstract][Full Text] [Related]
2. Association of specific DNA binding and transcriptional repression with the transforming and myogenic activities of c-Ski.
Nicol R; Zheng G; Sutrave P; Foster DN; Stavnezer E
Cell Growth Differ; 1999 Apr; 10(4):243-54. PubMed ID: 10319994
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal region of cellular Qin oligomerizes: correlation with oncogenic transformation and transcriptional repression.
Sonderegger CK; Narisawa-Saito M; Vogt PK
Oncogene; 2003 Apr; 22(13):1908-15. PubMed ID: 12673196
[TBL] [Abstract][Full Text] [Related]
4. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).
Chang CH; Scott GK; Baldwin MA; Benz CC
Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676
[TBL] [Abstract][Full Text] [Related]
5. Heterodimers of the SnoN and Ski oncoproteins form preferentially over homodimers and are more potent transforming agents.
Cohen SB; Zheng G; Heyman HC; Stavnezer E
Nucleic Acids Res; 1999 Feb; 27(4):1006-14. PubMed ID: 9927733
[TBL] [Abstract][Full Text] [Related]
6. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain.
Maurer P; T'Sas F; Coutte L; Callens N; Brenner C; Van Lint C; de Launoit Y; Baert JL
Oncogene; 2003 May; 22(21):3319-29. PubMed ID: 12761502
[TBL] [Abstract][Full Text] [Related]
7. The Ski oncoprotein interacts with Skip, the human homolog of Drosophila Bx42.
Dahl R; Wani B; Hayman MJ
Oncogene; 1998 Mar; 16(12):1579-86. PubMed ID: 9569025
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of mammalian transcriptional repressors.
Thiel G; Lietz M; Bach K; Guethlein L; Cibelli G
Biol Chem; 2001 Jun; 382(6):891-902. PubMed ID: 11501753
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic transformation by the FOX protein Qin requires DNA binding.
Ma Y; Geerdes DW; Vogt PK
Oncogene; 2000 Oct; 19(42):4815-21. PubMed ID: 11039897
[TBL] [Abstract][Full Text] [Related]
10. [Ski and SnoN: antagonistic proteins of TGFbeta signaling].
Vignais ML
Bull Cancer; 2000 Feb; 87(2):135-7. PubMed ID: 10705283
[TBL] [Abstract][Full Text] [Related]
11. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
Hermonat PL; Santin AD; Zhan D
J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions.
Peng H; Begg GE; Schultz DC; Friedman JR; Jensen DE; Speicher DW; Rauscher FJ
J Mol Biol; 2000 Feb; 295(5):1139-62. PubMed ID: 10653693
[TBL] [Abstract][Full Text] [Related]
13. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
14. The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation.
Bartholomew C; Kilbey A; Clark AM; Walker M
Oncogene; 1997 Feb; 14(5):569-77. PubMed ID: 9053855
[TBL] [Abstract][Full Text] [Related]
15. Sequence and biological activity of chicken snoN cDNA clones.
Boyer PL; Colmenares C; Stavnezer E; Hughes SH
Oncogene; 1993 Feb; 8(2):457-66. PubMed ID: 8426750
[TBL] [Abstract][Full Text] [Related]
16. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
17. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain.
Sarkar S; Gilmore TD
Oncogene; 1993 Aug; 8(8):2245-52. PubMed ID: 8336947
[TBL] [Abstract][Full Text] [Related]
18. Avian winged helix proteins CWH-1, CWH-2 and CWH-3 repress transcription from Qin binding sites.
Freyaldenhoven BS; Freyaldenhoven MP; Iacovoni JS; Vogt PK
Oncogene; 1997 Jul; 15(4):483-8. PubMed ID: 9242385
[TBL] [Abstract][Full Text] [Related]
19. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation.
Kamps MP; Wright DD; Lu Q
Oncogene; 1996 Jan; 12(1):19-30. PubMed ID: 8552391
[TBL] [Abstract][Full Text] [Related]
20. Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts.
Kilbey A; Bartholomew C
Oncogene; 1998 Apr; 16(17):2287-91. PubMed ID: 9619838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
